Bristol-Myers Squibb Co.

Links: Y! CELG MM R&D deep dive BMY Roulette CELG legacy IV board (still active) CELG legacy IV board (premium) BMY Roulette 2020

BMY / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
2910	Re: More advanced orva-cel (JCARH125) data at #ASCO20	GN	JBWIN		4	5/29/2020 11:12:18 AM

2909	More advanced orva-cel (JCARH125) data at #ASCO20	GN	zippypie		0	5/29/2020 10:50:20 AM

2908	its the little touches that makes me so comfortable with BMY's management team	GN	Mabel		6	5/29/2020 10:06:39 AM

2907	Re: Impressive Early Data for CC-92480 Presented by Dana Farber's Paul Richardson	GN	grafzeppelin	Strong Buy	2	5/29/2020 9:23:47 AM

2906	Impressive Early Data for CC-92480 Presented by Dana Farber's Paul Richardson	GN	JBWIN		13	5/29/2020 9:10:59 AM

2905	Tweets from ASCO on BB2121	GN	Biotech2050		12	5/29/2020 8:38:57 AM

2904	Bristol Myers Squibb to Hold Virtual Three-Part Investor Series (week of 22-26Jun2020)	GN	JBWIN		12	5/29/2020 7:40:04 AM

2903	ASCO20 starts in 2 hours	GN	Biotech2050		0	5/29/2020 6:02:03 AM

2902	Top ASCO picks by key opinion leaders	GN	Biotech2050		3	5/29/2020 12:00:01 AM

2901	Re: ASCO2020 Late-Breaking Abstract LBA3- KRd not statistically significantly better than VRd for PFS in NDMM (for BMY heads or tails, still Rd backbone; for AMGN 2nd gen-PI not better than Velcade)	GN	Biotech2050		0	5/28/2020 11:53:47 PM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement